Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (7): 741-746.doi: 10.3969/j.issn.1000-6621.2020.07.018
• Review Articles • Previous Articles Next Articles
JIANG Li*, ZHANG Xiao-qiang, LIU Ling-li, WANG Han, LIU Feng, LI Zhi-yue, SHEN Sheng-rong()
Received:
2020-03-02
Online:
2020-07-10
Published:
2020-07-09
Contact:
SHEN Sheng-rong
E-mail:shenshengrongzju@163.com
JIANG Li, ZHANG Xiao-qiang, LIU Ling-li, WANG Han, LIU Feng, LI Zhi-yue, SHEN Sheng-rong. Research progress of clinical characteristics of malnourished patients with tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 741-746. doi: 10.3969/j.issn.1000-6621.2020.07.018
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.07.018
文献第一作者 (年份) | 国 别 | 补充营 养类型 | 受试者 | 样本量 (例) | 饮食结构 | 结果 |
---|---|---|---|---|---|---|
Paton(2004)[ | 新 加 坡 | 蛋白质、 能量 | 成年结核病患者,体质量指数(BMI)<20 | 36 | 补充治疗组:建议饮食标准,额外添加含2510~3766kJ的安素(含25~37.5g蛋白质),为期6周 对照组:建议饮食标准,为期6周 | 补充治疗组与对照组在第12周均出现体质量增加,分别为2.6kg和0.8kg;体质量和握力增加 |
Martins(2009)[ | 东 帝 汶 | 蛋白质、 能量 | 成年结核病患者,80%的患者BMI<18.5 | 270 | 补充治疗组:建议饮食标准,额外添加含1799kJ的肉类(含18g蛋白质),2个月院内+6个月居家 对照组:建议饮食标准,2个月院内+6个月居家 | 补充治疗组与对照组在第8周体质量分别增加5.2kg和3.5kg |
Sudarsanam(2011)[ | 印 度 | 蛋白质、 维生素、 微量元素、 能量 | 成年结核病患者,BMI≤19,其中22例患者并发HIV感染,CD4+ T淋巴细胞≤200 个/μl | 103 | 建议饮食标准,额外添加谷物和豆类混合物,能量约为3891kJ,蛋白质含量约31.5g,为期6个月 对照组:建议饮食标准,为期6个月 | 组间结果差异无统计学意义,但补充治疗组的结核病及结核病并发HIV感染者都有改善的趋势 |
Jahnavi(2010)[ | 印 度 | 蛋白质、 维生素、 微量元素、 能量 | 成年结核病患者,BMI≤20 | 100 | 建议饮食标准,额外添加糖丸(一种补充能量的食物;含2510kJ能量和6g蛋白质),100g的坚果(用于补充维生素和矿物质),为期3个月 对照组:建议饮食标准,为期3个月 | 补充治疗组与对照组在第3个月均出现较为明显的体质量增加,分别为3.7kg 和1.1kg |
[1] | World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019. |
[2] | Sinha P, Davis J, Saag L, et al. Undernutrition and Tuberculosis: Public Health Implications. J Infect Dis, 2019,219(9):1356-1363. doi: 10.1093/infdis/jiy675. |
[3] | Chandrasekaran P, Saravanan N, Bethunaickan R, et al. Malnutrition: Modulator of Immune Responses in Tuberculosis. Front Immunol, 2017,8:1316. doi: 10.3389/fimmu.2017.01316. |
[4] | Bakari M, Wamsele J, MacKenzie T, et al. Nutritional status of HIV-infected women with tuberculosis in Dar es Salaam, Tanzania. Public Health Action, 2013,3(3):224-229. doi: 10.5588/pha.13.0028. |
[5] | Salamon H, Bruiners N, Lakehal K, et al. Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection. J Immunol, 2014,193(1):30-34. doi: 10.4049/jimmunol.1400736. |
[6] | 周宁, 杜祥博, 杨莉, 等. 不同病程的结核病患者的血浆代谢组学研究. 波谱学杂志, 2016,33(2):224-233. doi: 10.11938/cjmr20160205. |
[7] | Zhou A, Ni J, Xu Z, et al. Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J Proteome Res, 2013,12(10):4642-4649. doi: 10.1021/pr4007359. |
[8] | 车纾慧, 付玉荣, 尹正君. 结核分枝杆菌感染致巨噬细胞脂代谢改变的研究进展. 中国人兽共患病学报, 2018,34(11):1044-1048. doi: 10.3969/j.issn.1002-2694.2018.00.193. |
[9] | 张孝楠. 肺结核合并糖尿病患者的饮食及营养支持. 糖尿病新世界, 2016,19(14):106-107. doi: 10.16658/j.cnki.1672-4062.2016.14.106. |
[10] | 邵立群, 赵飒. 营养治疗对2型糖尿病合并肺结核患者的影响. 中国现代药物应用, 2018,12(14):185-186. doi: 10.14164/j.cnki.cn11-5581/r.2018.14.108. |
[11] | 陈荣娇, 梁志全, 杨荣, 等. 针对性饮食护理在老年肺结核伴糖尿病患者中的应用效果分析. 中国医药科学, 2018,8(12):167-169,192. doi: 10.3969/j.issn.2095-0616.2018.12.053. |
[12] | Paton NI, Chua YK, Earnest A, et al. Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. Am J Clin Nutr, 2004,80(2):460-465. doi: 10.1093/ajcn/80.2.460. |
[13] | Martins N, Morris P, Kelly PM. Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste. BMJ, 2009,339:b4248. doi: 10.1136/bmj.b4248. |
[14] | Sudarsanam TD, John J, Kang G, et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV-tuberculosis coinfection receiving directly observed short-course chemotherapy for tuberculosis. Trop Med Int Heal, 2011,16(6):699-706. doi: 10.1111/j.1365-3156.2011.02761.x. |
[15] | Jahnavi G, Sudha CH. Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Med J, 2010,51(12):957-962. |
[16] | World Health Organization. Guideline: Nutritional care and support for patients with tuberculosis. Geneva: World Health Organization, 2013. |
[17] | 车纾慧, 付玉荣, 尹正君. 结核分枝杆菌感染致巨噬细胞脂代谢改变的研究进展. 中国人兽共患病学报, 2018,34(11):1044-1048. doi: 10.3969/j.issn.1002-2694.2018.00.193. |
[18] | 刘国平. 结核病与血脂水平的相关性研究. 黑龙江医学, 2009,33(11):852-853. doi: 10.3969/j.issn.1004-5775.2009.11.023. |
[19] | 崔学青, 付玉荣, 尹正君. 结核分枝杆菌感染对巨噬细胞内胆固醇代谢影响的机制的研究进展. 中国病原微生物学杂志, 2018,13(5):553-555. doi: 10.13350/j.cjpb.180523. |
[20] | 李月, 刘凯, 方柯红, 等. 肺结核患者的膳食模式及其影响因素城乡差异的研究. 中国卫生统计, 2018,35(1):64-67. |
[21] | 郑秀丽, 赖小惠, 梁月贞, 等. 高胆固醇饮食对肺结核患者相关指标改善情况分析. 延安大学学报(医学科学版), 2020,18(1):76-78. |
[22] | Aibana O, Franke MF, Huang CC, et al. Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression. Clin Infect Dis, 2017,65(6):900-909. doi: 10.1093/cid/cix476. |
[23] | Karyadi E, Schultink W, Nelwan RH, et al. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr, 2000,130(12):2953-2958. doi: 10.1093/jn/130.12.2953. |
[24] | Mugusi FM, Rusizoka O, Habib N, et al. Vitamin A status of patients presenting with pulmonary tuberculosis and asymptomatic HIV-infected individuals, Dar es Salaam, Tanzania. Int J Tuberc Lung Dis, 2003,7(8):804-807. |
[25] | Rwangabwoba JM, Fischman H, Semba RD. Serum vitamin A levels during tuberculosis and human immunodeficiency virus infection. Int J Tuberc Lung Dis, 1998,2(9):771-773. |
[26] | Ramachandran G, Santha T, Garg R, et al. Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy ‘normals’. Int J Tuberc Lung Dis, 2004,8(9):1130-1133. |
[27] | Kant S, Gupta H, Ahluwalia S. Significance of nutrition in pulmonary tuberculosis. Crit Rev Food Sci Nutr, 2015,55(7):955-963. doi: 10.1080/10408398.2012.679500. |
[28] | Mishra A, Sarkar D. Qualitative and quantitative proteomic analysis of Vitamin C induced changes in Mycobacterium smegmatis. Front Microbiol, 2015,6:451. doi: 10.3389/fmicb.2015.00451. |
[29] | Tornheim JA, Dooley KE. Tuberculosis Associated with HIV Infection. Microbiol Spectr, 2017,5(1). doi: 10.1128/microbiolspec.TNMI7-0028-2016. |
[30] | Vilchèze C, Hartman T, Weinrick B, et al. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nat Commun, 2013,4:1881. doi: 10.1038/ncomms2898. |
[31] | 李新庆, 陈铁龙, 罗微. 高剂量维生素C辅助治疗继发性肺结核效果观察. 护理研究 2017,31(16):2019-2020. doi: 10.3969/j.issn.1009-6493.2017.16.029. |
[32] | Khameneh B, Fazly Bazzaz BS, Amani A, et al. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb Pathog, 2016,93:83-87. doi: 10.1016/j.micpath.2015.11.006. |
[33] | Zeng J, Wu G, Yang W, et al. A serum vitamin D level <25 nmol/l pose high tuberculosis risk: a meta-analysis. PLoS One, 2015,10(5):e0126014. doi: 10.1371/journal.pone.0126014. |
[34] | Luong Kv, Nguyen LT. Impact of vitamin D in the treatment of tuberculosis. Am J Med Sci, 2011,341(6):493-498. doi: 10.1097/MAJ.0b013e3182070f47. |
[35] | Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones, 2006,38(1):3-5. |
[36] | Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomi-zed, placebo-controlled trial. Am J Respir Crit Care Med, 2009,179(9):843-850. doi: 10.1164/rccm.200804-567OC. |
[37] | Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr, 2010,104(10):1487-1491. doi: 10.1017/S0007114510002333. |
[38] | Ciftci TU, Ciftci B, Yis O, et al. Changes in serum selenium, copper, zinc levels and cu/zn ratio in patients with pulmonary tuberculosis during therapy. Biol Trace Elem Res, 2003,95(1):65-71. doi: 10.1385/BTER:95:1:65. |
[39] | Koyanagi A, Kuffó D, Gresely L, et al. Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis. Ann Trop Med Parasitol, 2004,98(4):391-399. doi: 10.1179/000349804225003424. |
[40] | Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999,340(6):448-454. doi: 10.1056/NEJM199902113400607. |
[41] | Graham NM, Sorensen D, Odaka N, et al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr, 1991,4(10):976-980. |
[42] | Ramakrishnan K, Shenbagarathai R, Kavitha K, et al. Selenium levels in persons with HIV/tuberculosis in India, Madurai City. Clin Lab, 2012,58(1/2):165-168. |
[43] | 李微, 张万江. 微量铁元素在结核病发病机制中作用的研究进展. 细胞与分子免疫学杂志, 2012,28(5):554-556. |
[44] | Soeharto DA, Rifai DA, Marsudidjadja S, et al. Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report. Adv Prev Med, 2019: 5181847. doi: 10.1155/2019/5181847. |
[45] | Feleke BE, Feleke TE, Mekonnen D, et al. Micronutrient levels of tuberculosis patients during the intensive phase, a prospective cohort study. Clin Nutr ESPEN, 2019,31:56-60. doi: 10.1016/j.clnesp.2019.03.001. |
[46] | Panda S, Tiwari A, Luthra K, et al. Status of vitamin D and the associated host factors in pulmonary tuberculosis patients and their household contacts: A cross sectional study. J Steroid Biochem Mol Biol, 2019,193:105419. doi: 10.1016/j.jsbmb.2019.105419. |
[47] | Khameneh B, Fazly Bazzaz BS, Amani A, et al. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb Pathog, 2016,93:83-87. doi: 10.1016/j.micpath.2015.11.006. |
[48] | Elsafi SSMS, Nour BM, Abakar AD, et al. Vitamin D level and it is association with the severity of pulmonary tuberculosis in patients attended to Kosti Teaching Hospital, Sudan. AIMS Microbiol, 2020,6(1):65-74. doi: 10.3934/microbiol.2020004. |
[49] | Kim EW, De Leon A, Jiang Z, et al. Vitamin A Metabolism by Dendritic Cells Triggers an Antimicrobial Response against Mycobacterium tuberculosis. mSphere, 2019,4(3):e00327-19. doi: 10.1128/mSphere.00327-19. |
[50] | Nazarova EV, Montague CR, La T, et al. Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis. Elife, 2017,6:e26969. doi: 10.7554/eLife.26969. |
[51] | Wada T, Hanibuchi M, Saijo A. Acute hypercalcemia and hypervitaminosis D associated with pulmonary tuberculosis in an elderly patient: A case report and review of the literature. J Med Invest, 2019,66(3/4):351-354. doi: 10.2152/jmi.66.351. |
[52] | Wilburn K, Fieweger RA, VanderVen BC. Cholesterol and fatty acids grease the wheels of Mycobacterium tuberculosis pathogenesis. Pathogens and Disease, 2019,76:1-14. doi: 10.1155/2019/5181847. |
[53] | 何广学. 我国结核病防治机构感染控制工作面临的挑战与对策. 结核病与肺部健康杂志, 2018,7(2):85-87. doi: 10.3969/j.issn.2095-3755.2018.02.001. |
[54] | 中华医学会结核病学分会重症专业委员会. 结核病营养治疗专家共识. 中华结核和呼吸杂志, 2020,43(1):17-26. doi: 10.3760/cma.j.issn.1001-0939.2020.01.006. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||